Scimago Institutions Rankings
menu
| Title | Type |  SJR |
H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Drug Design, Development and Therapy | journal | 0.979 Q2 | 54 | 150 | 119 | 7621 | 482 | 114 | 4.25 | 50.81 |  |
| 2 | Biomarker Insights | journal | 0.793 Q2 | 28 | 15 | 53 | 604 | 142 | 52 | 2.42 | 40.27 | |
| 3 | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | journal | 0.701 Q2 | 39 | 51 | 71 | 2388 | 193 | 69 | 2.91 | 46.82 | |
| 4 | Core Evidence (discontinued) | journal | 0.685 Q2 | 22 | 7 | 29 | 442 | 81 | 28 | 3.58 | 63.14 | |
| 5 | Infection and Drug Resistance | journal | 0.601 Q2 | 32 | 27 | 47 | 1454 | 121 | 46 | 2.79 | 53.85 | |
| 6 | Pharmacogenomics and Personalized Medicine | journal | 0.572 Q2 | 25 | 17 | 33 | 996 | 72 | 33 | 2.64 | 58.59 | |
| 7 | Journal of Receptor, Ligand and Channel Research | journal | 0.481 Q3 | 7 | 2 | 12 | 279 | 22 | 11 | 0.33 | 139.50 | |
| 8 | Drug, Healthcare and Patient Safety | journal | 0.347 Q3 | 20 | 25 | 58 | 765 | 85 | 57 | 1.67 | 30.60 | |
| 9 | Journal of Experimental Pharmacology | journal | 0.129 Q4 | 9 | 1 | 3 | 166 | 2 | 3 | 0.50 | 166.00 | |
| 10 | Perspectives in Medicinal Chemistry | journal | 0.121 Q4 | 16 | 0 | 6 | 0 | 3 | 5 | 0.50 | 0.00 | |
| 11 | Clinical Medicine Insights: Therapeutics | journal | 0.117 Q4 | 8 | 13 | 105 | 1049 | 30 | 105 | 0.32 | 80.69 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2020. Data Source: Scopus®
Download data